CA Patent

CA2938919C — Charged linkers and their uses for conjugation

Assigned to Hangzhou Dac Biotech Co Ltd · Expires 2020-12-29 · 5y expired

What this patent protects

Cell binding agent-drug conjugates comprising phosphinate-based charged linkers and methods of using such linkers and conjugates are provided.

USPTO Abstract

Cell binding agent-drug conjugates comprising phosphinate-based charged linkers and methods of using such linkers and conjugates are provided.

Drugs covered by this patent

lutetium-lu-177-vipivotide-tetraxetan (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN)

Patent Metadata

Patent number: CA2938919C
Jurisdiction: CA
Classification: —
Expires: 2020-12-29
Drug substance claim: No
Drug product claim: No
Assignee: Hangzhou Dac Biotech Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.